Back to today’s briefing

Story perspectives

Switzerland Approves First Malaria Treatment for Infants

7/8/2025

34 3

Summary

Story summary

Switzerland has taken a monumental step in the fight against malaria by approving Coartem Baby, the first-ever treatment for infants under 4.5 kg, created by Novartis. This groundbreaking drug fills a vital void in care for vulnerable newborns. Eight African nations are set to follow suit within 90 days, paving the way for a swift, not-for-profit rollout.

1 of 1

Story summary

Switzerland has taken a monumental step in the fight against malaria by approving Coartem Baby, the first-ever treatment for infants under 4.5 kg, created by Novartis. This groundbreaking drug fills a vital void in care for vulnerable newborns. Eight African nations are set to follow suit within 90 days, paving the way for a swift, not-for-profit rollout.